You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 6, June 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (94)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Schizophrenia
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Decreased Serum Levels of D-Serine in Patients With Schizophrenia

Evidence in Support of the N-Methyl-D-Aspartate Receptor Hypofunction Hypothesis of Schizophrenia

Kenji Hashimoto, PhD; Takeshi Fukushima, PhD; Eiji Shimizu, MD, PhD; Naoya Komatsu, MD, PhD; Hiroyuki Watanabe, MD, PhD; Naoyuki Shinoda, MD, PhD; Michiko Nakazato, MD, PhD; Chikara Kumakiri, MD, PhD; Shin-ichi Okada, MD, PhD; Hisanori Hasegawa, BS; Kazuhiro Imai, PhD; Masaomi Iyo, MD, PhD

Arch Gen Psychiatry. 2003;60:572-576.

Background  The hypofunction of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors has been implicated in the pathophysiology of schizophrenia. Several lines of evidence suggest that D-serine may function as an endogenous agonist of the glycine site of the NMDA receptor. The aim of this study was to examine whether serum levels of D- and L-serine in patients with schizophrenia are different from those of healthy controls.

Methods  Forty-two patients with schizophrenia and 42 age- and sex-matched healthy controls were enrolled in this study. Symptoms were assessed using the Brief Psychiatric Rating Scale. Serum levels of total serine and D- and L-serine were measured by high-performance liquid chromatography.

Results  Serum levels of D-serine in the patients with schizophrenia were significantly (z = -3.30, P = .001) lower than those of healthy controls. In contrast, serum levels of total (D and L) serine (z = -2.40, P = .02) and L-serine (z = -2.49, P = .01) in the schizophrenic patients were significantly higher than those of controls. In addition, the percentage of D-serine in the total serine in the schizophrenic patients was significantly (z = -4.78, P<.001) lower than that of controls, suggesting that the activity of serine racemase, an enzyme catalyzing the formation of D-serine from L-serine, may have been reduced in the schizophrenic patients.

Conclusions  Reduced levels of D-serine may play a role in the pathophysiology of schizophrenia, and serum D- and L-serine levels might provide a measurable biological marker for schizophrenia.


From the Department of Psychiatry, Graduate School of Medicine, Chiba University, Chiba (Drs Hashimoto, Shimizu, Komatsu, Watanabe, Shinoda, Nakazato, Kumakiri, Okada, and Iyo), and Department of Bio-Analytical Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo (Drs Fukushima and Imai and Mr Hasegawa), Japan.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

When Top-Down Meets Bottom-Up: Auditory Training Enhances Verbal Memory in Schizophrenia
Adcock et al.
Schizophr Bull 2009;35:1132-1141.
ABSTRACT | FULL TEXT  

Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model
Labrie et al.
Hum Mol Genet 2009;18:3227-3243.
ABSTRACT | FULL TEXT  

The Behavioral and Neurochemical Effects of a Novel D-Amino Acid Oxidase Inhibitor Compound 8 [4H-Thieno [3,2-b]pyrrole-5-carboxylic Acid] and D-Serine
Smith et al.
J. Pharmacol. Exp. Ther. 2009;328:921-930.
ABSTRACT | FULL TEXT  

Genetic inactivation of D-amino acid oxidase enhances extinction and reversal learning in mice
Labrie et al.
Learn. Mem. 2008;16:28-37.
ABSTRACT | FULL TEXT  

Bell-Shaped D-Serine Actions on Hippocampal Long-Term Depression and Spatial Memory Retrieval
Zhang et al.
Cereb Cortex 2008;18:2391-2401.
ABSTRACT | FULL TEXT  

Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection
Lieberman et al.
Pharmacol. Rev. 2008;60:358-403.
ABSTRACT | FULL TEXT  

CSF Serine Enantiomers and Glycine in the Study of Neurologic and Psychiatric Disorders
Hashimoto
Clin. Chem. 2008;54:1413-1414.
FULL TEXT  

Two Mass-Spectrometric Techniques for Quantifying Serine Enantiomers and Glycine in Cerebrospinal Fluid: Potential Confounders and Age-Dependent Ranges
Fuchs et al.
Clin. Chem. 2008;54:1443-1450.
ABSTRACT | FULL TEXT  

Disposition of D-Serine in Healthy Adults
Tsai et al.
J Clin Pharmacol 2008;48:524-527.
FULL TEXT  

Simultaneous Analysis of D- and L-Serine in Cerebrospinal Fluid by Use of HPLC
Sethuraman et al.
Clin. Chem. 2007;53:1489-1494.
ABSTRACT | FULL TEXT  

Identification of Functional Polymorphisms in the Promoter Region of the Human PICK1 Gene and Their Association With Methamphetamine Psychosis
Matsuzawa et al.
Am. J. Psychiatry 2007;164:1105-1114.
ABSTRACT | FULL TEXT  

Relation of Plasma Glycine, Serine, and Homocysteine Levels to Schizophrenia Symptoms and Medication Type
Neeman et al.
Am. J. Psychiatry 2005;162:1738-1740.
ABSTRACT | FULL TEXT  

The NMDA Hypothesis for Schizophrenia
JWatch Psychiatry 2003;2003:3-3.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.